Global Kidney Patient Trials Network

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04389827

Acronym

GKPTN

Enrollment

5999

Registered

2020-05-15

Start date

2020-05-05

Completion date

2025-10-31

Last updated

2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Diseases

Keywords

Chronic Kidney Disease, Diabetic Nephropathy, Hypertensive Kidney Disease, Glomerulonephritis (GN), Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy, Minimal Change Disease, Immunoglobulin A Nephropathy (IgAN), Glomerulonephritis not otherwise specified, GN, FSGS

Brief summary

This is a prospective international multi-centre, observational cohort study of incident and prevalent patients diagnosed with a kidney disease

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

2 Years to 80 Years

Healthy volunteers

Inclusion criteria

1. Documented diagnosis of primary kidney disease 2. Regular visits (6-12 monthly) with a physician at a participating site that includes the monitoring of protein in urine and kidney function 3. eGFR \> 25 ml/min/1.73m2 4. ≥ 2 to ≥ 80 years of age 5. One of the following laboratory urine parameters within 12 months of screening meeting the values of: * Urine Albumin-to-Creatinine Ratio (UACR) \> 200 mg/g OR * Protein-to-Creatinine Ratio (PCR) \> 300 mg/g OR * Albumin Excretion Rate (AER) \> 200 mg/day OR * 24 hour Albumin Excretion \> 200 mg/day OR * 24 hour Urine Protein Excretion \> 300 mg/day 6. Willing and able to sign informed consent 7. Willing to be approached about participation in interventional research studies

Exclusion criteria

1. Life-expectancy of less than 6 months 2. Currently receiving renal replacement therapy or planned to start in the next 6 months 3. Planned transplant in the next 6 months 4. Currently participating in a clinical trial involving investigational medicinal product (exception is participation in studies implemented through the GKPTN)

Design outcomes

Primary

Measure	Time frame	Description
estimated Glomerular Filtration Rate (eGFR)	Collected Six-Monthly (minimum)	Routine results
Albuminuria	Collected Six-Monthly (minimum)	Routine results

Countries

Australia

Outcome results